"Pillar Biosciences said Wednesday that more of its OncoReveal next-generation sequencing panels will be offered by Illumina in an expansion of the companies’ existing partnership...The deal includes the OncoReveal Essential MPN, Myeloid, Multi-Cancer with CNV and Fusion panel, and BRCA1 and BRCA2 plus CNV panel, which will be available as part of validated workflows on the MiSeq i100 sequencer launched last week."
1 month ago
Licensing / partnership
|
OncoReveal™ BRCA1 & BRCA2 plus CNV Panel • OncoReveal™ Myeloid Panel • oncoReveal™ Core LBx • oncoReveal™ Fusion LBx Panel • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel